News

This new technology will enable surgeons to perform treatments more accurately and comfortably in a short period of time.

Diagnostic and prognostic capabilities at the early stages of retinal diseases could be improved as a result of adaptive optics.

Dr Sebasiten Wolf describes how SD-OCT has improved the visualization of intraretinal morphologic feaures both quantatively and qualatively.

According to a study published in Investigative Ophthalmology and Visual Science more research into the effect of sustained-release ciliary neurotrophic factor (CNTF) treatment, on patients with inherited retinal degenerations, using high-resolution imaging techniques is required.

A study published in Clinical Ophthalmology has proved the efficacy of using polydimethyloxane (PDMS) and perfluoro-n-octane (PFO) as tamponade in patients with retinal detachment complicated by proliferative vitreoretinopathy (PVR).

Optical Biometry

Dr Paul-Rolf Preussner discusses how additional optical measurements are required to improve the accuracy limits in IOL calculation

IOL power: Quo vadis?

Increasing levels of expectations of refractive results is challenging IOL power calculations, reveals Dr Oliver Findl

Following a premium IOL implantation it is now possible to maintain the target refractive error of 0.5 D but errors can still arise in the calculation of the desired IOL power. Modernizing formulae may help to reduce prediction error in IOL power calculations.

Results of an in vitro study of the potentially adverse efefcts of five different topical glaucoma medications and preservatives are revealed

A novel nanosecond laser therapy has stopped the progression of age-related macular degeneration (AMD) and resulted in resolution of drusen and improved visual function in patients with early-stage high-risk AMD.